Skip to main content
Law360

‘Bad Actor' Waivers Spark Opposing Views Within SEC

May 18, 2015
Authors
Ike AdamsChristopher R. Mills

Recent speeches by U.S. Securities and Exchange Commission commissioners have shed further light on the ongoing debate among the commissioners about how the SEC should exercise its discretion when deciding whether to grant waivers from the statutory disqualification provisions of the federal securities laws.

View Article

Contacts

Adams, Ike
Partner
Mills, Christopher R.
Partner

Capabilities

Suggested News & Insights

Houston Chief Compliance Officer RoundtableWednesday, April 29, 2026
Events
Sidley Represents HealthCare Royalty in Monetization Agreement for Modeyso Commercial RoyaltiesApril 24, 2026
Announcements
U.S. SEC Options Market Structure Roundtable Contemplates Targeted Reforms to Modernize Options MarketsApril 23, 2026
Securities Enforcement and Regulatory Update
Sonia Gupta Barros to Speak at PLI’s 2026 Global Capital Markets & the U.S. Securities Laws ProgramTuesday, April 21, 2026
Speaking Engagements
Sidley Represents Galera Therapeutics in Its Merger With Obsidian Therapeutics and US$350 Million Private Placement FinancingApril 21, 2026
Announcements
FinCEN, Office of Foreign Assets Control Propose Anti-Money-Laundering Program and Sanctions Requirements for Stablecoin IssuersApril 20, 2026
Securities Enforcement and Regulatory Update